TMS Therapy: Transcranial Magnetic Stimulation for Depression

Repetitive transcranial magnetic stimulation (rTMS), usually shortened to TMS, is a non-invasive brain stimulation treatment delivered in specialist clinics. It is used mainly for adults with depression that has not responded adequately to medication and psychotherapy. This article describes what TMS is, what a treatment course involves, what the evidence supports, its safety profile, and the situations in which it may be considered. It is descriptive only — TMS is a medical procedure prescribed and delivered by clinicians.

Table of Contents

1. What is TMS?
2. What a Treatment Course Looks Like
3. What the Evidence Says
4. Safety and Side Effects
5. Who It May Be Considered For
6. Common Misconceptions
7. Related Reading
8. References

What is TMS?

TMS uses a padded electromagnetic coil placed against the scalp. The coil delivers short magnetic pulses that pass painlessly through the skull and induce small electrical currents in the outer layers of the brain (the cortex). Depending on the target region and stimulation parameters, these currents can modulate the activity of neural circuits.

The procedure is:

• Non-invasive — nothing enters the body; there is no surgery or implantation.
• Performed without anesthesia or sedation — the person remains awake and alert throughout, and can usually drive home afterwards.
• Clinic-based — the stimulation device and dosing are controlled by a clinical team; consumer magnetic products are unrelated.

The most studied application is stimulation of the left dorsolateral prefrontal cortex, a region involved in mood regulation, for major depressive disorder. This article focuses on that use.

What a Treatment Course Looks Like

TMS is an outpatient procedure delivered by a clinical team over a defined course. In broad terms:

• Frequency: sessions are typically given once per day on weekdays.
• Duration: a first course commonly spans roughly four to six weeks.
• Session length: sessions vary in length depending on the stimulation protocol used; many people spend well under an hour in the chair and can return to normal activity immediately.
• During a session: the person sits in a treatment chair, the coil is positioned and calibrated, and they simply remain awake while pulses are delivered — a series of clicks and tapping sensations on the scalp.

Specific stimulation parameters, session counts, and course length are medical decisions made by the prescribing clinician for the individual. The description here is general and is not a prescription. Some people continue with medication and psychotherapy alongside TMS; maintenance plans after a successful course also vary.

What the Evidence Says

Randomized controlled evidence. The pivotal multisite randomized controlled trial by O'Reardon et al. (2007) found that active left prefrontal TMS produced significantly greater improvement in depression symptoms than sham stimulation in adults whose depression had not responded to medication. George et al. (2010), in a larger sham-controlled trial of daily left prefrontal rTMS, found higher remission rates with active treatment, again in a medication-resistant population. Together these trials established that the effect is not purely placebo.

Real-world effectiveness. Carpenter et al. (2012) followed patients receiving TMS in routine clinical practice across multiple sites and reported meaningful improvement and remission rates consistent with — and in some respects more favorable than — the controlled trials, supporting that the treatment translates to everyday settings.

Regulatory status. TMS devices for depression have been cleared or approved by regulatory authorities in multiple jurisdictions, including the United States and Europe, for adults with depression who have not benefited from earlier treatments. The specifics differ by country and device; this article does not make device-specific claims.

Honest caveats. Effects in the controlled trials, while statistically reliable, were moderate on average — many participants improved, but remission was not universal, and some gained little. Sham stimulation is an imperfect control condition because it can still produce scalp sensation, which may slightly blur comparisons. There is also limited head-to-head evidence comparing TMS with other second-line options (for example, switching medications or certain psychotherapies), so decisions often rest on individual factors rather than proven superiority.

Safety and Side Effects

TMS is generally well tolerated in supervised clinical settings. Common effects include:

• Scalp discomfort or pain at the coil site during sessions, usually strongest early in the course.
• Headache after sessions, typically mild to moderate and short-lived.

Less common effects can include hearing discomfort (earplugs are worn during treatment) and, rarely, facial muscle twitching during stimulation. The most serious known risk — a seizure induced by stimulation — is rare and is managed through strict screening and dosing protocols.

How TMS differs from ECT. TMS is sometimes confused with electroconvulsive therapy (ECT). They are distinct procedures: ECT requires anesthesia and deliberately induces a seizure, and is more commonly associated with temporary memory side effects. TMS involves no anesthesia, no seizure, and no established memory impairment, with a far milder overall side-effect profile. Both are legitimate medical treatments with different indications; neither is a first step.

Who It May Be Considered For

TMS is generally considered for adults with major depressive disorder who have not responded adequately to medication trials — the situation often called treatment-resistant depression. It is delivered in specialist settings after a psychiatric evaluation that reviews diagnosis, prior treatments, and any factors that would make stimulation unsafe (for example, certain metal implants in or near the head, or a high seizure risk).

Suitability is an individual medical judgment. Screening questionnaires such as the PHQ-9 can help describe depression severity in preparation for a professional conversation, but they do not determine whether any particular treatment is appropriate.

Common Misconceptions

• "TMS is electroshock therapy." It is not ECT. No anesthesia, no induced seizure, no electric current applied to the head in the ECT sense.
• "It's the same as magnetic therapy products." Consumer magnets and wearable "magnetic" gadgets have nothing in common with a calibrated medical stimulation device operated by a clinical team.
• "It's experimental." Pivotal sham-controlled trials and regulatory clearances date back more than a decade, and naturalistic studies cover routine practice. Debates continue about effect size and positioning among second-line options, but calling it untested misstates the record.
• "It cures depression." A course can produce substantial relief for some people; others respond partially or not at all. Ongoing care planning usually follows.
• "You can buy a device and self-treat." TMS is a prescribed medical procedure. Self-administered stimulation devices are a different, unregulated category and are not equivalent.

Related Reading

• Depression — symptoms, mechanisms, and coping with depression
• Major Depression — the condition TMS is most often considered for
• Behavioral Activation — a structured psychotherapy approach for depression
• ACT Therapy and DBT Therapy — psychotherapy options with evidence for mood difficulties
• PHQ-9 — a standard self-report screening tool for depression
• EMDR Therapy — another specialized, clinician-delivered treatment with a different profile

References

• O'Reardon et al. (2007). Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biological Psychiatry, 62(11), 1208-1216.
• Carpenter et al. (2012). Transcranial magnetic stimulation (TMS) for major depression: A multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety, 29(7), 587-596.
• George et al. (2010). Daily left prefrontal repetitive transcranial magnetic stimulation for the treatment of major depression: A sham-controlled trial. Archives of General Psychiatry, 67(5), 507-516.

Important Disclaimer

This page is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. TMS is a medical procedure prescribed and delivered by qualified clinicians in specialist settings; it is never a self-treatment. Always consult a qualified healthcare provider about whether any treatment is appropriate for your situation. If you are in crisis, contact your local emergency services or a crisis helpline immediately.